CA3186997A1 - Methods for detecting and predicting cancer and/or cin3 - Google Patents
Methods for detecting and predicting cancer and/or cin3Info
- Publication number
- CA3186997A1 CA3186997A1 CA3186997A CA3186997A CA3186997A1 CA 3186997 A1 CA3186997 A1 CA 3186997A1 CA 3186997 A CA3186997 A CA 3186997A CA 3186997 A CA3186997 A CA 3186997A CA 3186997 A1 CA3186997 A1 CA 3186997A1
- Authority
- CA
- Canada
- Prior art keywords
- seq
- cpgs
- cancer
- assay
- nos
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2537/00—Reactions characterised by the reaction format or use of a specific feature
- C12Q2537/10—Reactions characterised by the reaction format or use of a specific feature the purpose or use of
- C12Q2537/165—Mathematical modelling, e.g. logarithm, ratio
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/154—Methylation markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Steroid Compounds (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2009224.3A GB202009224D0 (en) | 2020-06-17 | 2020-06-17 | Methods for detecting and predicting cancer and/or cin3 |
| GB2009224.3 | 2020-06-17 | ||
| GBGB2107412.5A GB202107412D0 (en) | 2021-05-25 | 2021-05-25 | Methods for detecting and predicting cancer and/or CIN3 |
| GB2107412.5 | 2021-05-25 | ||
| PCT/GB2021/051536 WO2021255459A1 (en) | 2020-06-17 | 2021-06-17 | Methods for detecting and predicting cancer and/or cin3 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3186997A1 true CA3186997A1 (en) | 2021-12-23 |
Family
ID=76730905
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3186997A Pending CA3186997A1 (en) | 2020-06-17 | 2021-06-17 | Methods for detecting and predicting cancer and/or cin3 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240191302A1 (https=) |
| EP (1) | EP4168587A1 (https=) |
| JP (1) | JP2023530983A (https=) |
| KR (1) | KR20230024344A (https=) |
| AU (1) | AU2021291133A1 (https=) |
| BR (1) | BR112022025789A2 (https=) |
| CA (1) | CA3186997A1 (https=) |
| IL (1) | IL299142A (https=) |
| MX (1) | MX2022016100A (https=) |
| WO (1) | WO2021255459A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB202315787D0 (en) * | 2023-10-16 | 2023-11-29 | Sola Diagnostics Gmbh | Method |
| GB202401477D0 (en) * | 2024-02-05 | 2024-03-20 | Sola Diagnostics Gmbh | Method |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013033627A2 (en) * | 2011-09-01 | 2013-03-07 | The Regents Of The University Of California | Diagnosis and treatment of arthritis using epigenetics |
| WO2016041010A1 (en) * | 2014-09-15 | 2016-03-24 | Garvan Institute Of Medical Research | Methods for diagnosis, prognosis and monitoring of breast cancer and reagents therefor |
| US9984201B2 (en) * | 2015-01-18 | 2018-05-29 | Youhealth Biotech, Limited | Method and system for determining cancer status |
| JP7299158B2 (ja) * | 2017-03-10 | 2023-06-27 | セルフ－スクリーン ベー．フェー． | Ｈｐｖ誘発浸潤がん、非ｈｐｖ誘発婦人科がん及び肛門性器がん、並びにその高度前駆病変を検出するためのメチル化分類子 |
| US12480164B2 (en) * | 2018-12-04 | 2025-11-25 | EpiMedTechGlobal (EMTG) | DNA methylation biomarkers for early detection of cervical cancer |
-
2021
- 2021-06-17 US US18/009,945 patent/US20240191302A1/en active Pending
- 2021-06-17 AU AU2021291133A patent/AU2021291133A1/en active Pending
- 2021-06-17 JP JP2022577444A patent/JP2023530983A/ja active Pending
- 2021-06-17 KR KR1020237000635A patent/KR20230024344A/ko active Pending
- 2021-06-17 WO PCT/GB2021/051536 patent/WO2021255459A1/en not_active Ceased
- 2021-06-17 BR BR112022025789A patent/BR112022025789A2/pt unknown
- 2021-06-17 EP EP21736665.7A patent/EP4168587A1/en active Pending
- 2021-06-17 MX MX2022016100A patent/MX2022016100A/es unknown
- 2021-06-17 CA CA3186997A patent/CA3186997A1/en active Pending
- 2021-06-17 IL IL299142A patent/IL299142A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX2022016100A (es) | 2023-04-20 |
| BR112022025789A2 (pt) | 2023-01-10 |
| WO2021255459A1 (en) | 2021-12-23 |
| JP2023530983A (ja) | 2023-07-20 |
| AU2021291133A1 (en) | 2023-02-02 |
| KR20230024344A (ko) | 2023-02-20 |
| EP4168587A1 (en) | 2023-04-26 |
| US20240191302A1 (en) | 2024-06-13 |
| IL299142A (en) | 2023-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2703769T3 (es) | Biomarcadores de ácidos nucleicos en circulación asociados al cáncer de mama | |
| ME03551B (me) | Humanizovane nehumane živoтinje sa ograničenim lokusima imunoglobulinskog тeškog lanca | |
| JP5236286B2 (ja) | 肝線維症に関連する遺伝的多型、その検出方法および使用 | |
| CA3060721C (en) | Method of diagnosing bladder cancer. | |
| CA2818887A1 (en) | Diagnostic and/or screening agents and uses therefor | |
| US20210332440A1 (en) | Detection of advanced adenoma and/or early stage colorectal cancer | |
| CA2929826A1 (en) | Method for selecting and treating lymphoma types | |
| US20210395828A1 (en) | Methylation modification-based tumor marker stamp-ep1 | |
| CA3186997A1 (en) | Methods for detecting and predicting cancer and/or cin3 | |
| JP2010263894A (ja) | 癌における治療標的 | |
| EP1476067A2 (en) | Novel compositions and methods for cancer | |
| JP2009521205A (ja) | 発作に関連する遺伝的多型、その検出方法および使用 | |
| WO2016097059A1 (en) | Compositions and methods for diagnosing thyroid cancer | |
| CA3231249A1 (en) | Coronavirus rapid diagnostics | |
| CN110753761A (zh) | 检测hpv诱导的浸润性癌症、非hpv诱导的妇科癌症和肛门生殖器癌症以及它们的高级前体病变的甲基化分类器 | |
| CA3187000A1 (en) | Methods for detecting and predicting grade 3 cervical epithelial neoplasia (cin3) and/or cancer | |
| JP2006521812A (ja) | 慢性関節リウマチに関連する遺伝的多型、その検出方法および使用 | |
| WO2016070164A1 (en) | Assays for single molecule detection and use thereof | |
| KR101287431B1 (ko) | 표적 유전자의 다양한 변이가 존재하는 유전자 영역을 증폭하기 위한 프라이머 조성물, 이를 이용한 표적 유전자 증폭 방법 및 이를 포함하는 ｐｃｒ 증폭 키트 그리고 이를 이용한 표적 유전자의 유전자형 분석방법 | |
| JP2009523006A (ja) | 脈管疾患に関連する遺伝的多型、その検出方法および使用 | |
| AU2016224709B2 (en) | Method for assisting in prognostic diagnosis of colorectal cancer, recording medium and determining device | |
| CN115141886B (zh) | 一种基于高通量测序的髓系白血病基因突变检测的探针引物组及其应用 | |
| JP2009523405A (ja) | 冠動脈心疾患に関連する遺伝的多型、その検出方法および使用 | |
| US20090305903A1 (en) | Methods and compositions for diagnosis, monitoring and development of therapeutics for treatment of atherosclerotic disease | |
| WO2022189445A1 (en) | Cardiovascular disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| D11 | Substantive examination requested |
Free format text: ST27 STATUS EVENT CODE: A-1-1-D10-D11-D117 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST FOR EXAMINATION RECEIVED Effective date: 20250505 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-1-1-P10-P11-P101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT RECEIVED - VOLUNTARY AMENDMENT Effective date: 20250505 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20250505 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20250506 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 4TH ANNIV.) - STANDARD Year of fee payment: 4 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20250523 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20250523 |
|
| D00 | Search and/or examination requested or commenced |
Free format text: ST27 STATUS EVENT CODE: A-1-1-D10-D00-D118 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST FOR EXAMINATION REQUIREMENTS DETERMINED COMPLIANT Effective date: 20250721 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-1-1-P10-P11-P102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT DETERMINED COMPLIANT Effective date: 20250721 |
|
| P13 | Application amended |
Free format text: ST27 STATUS EVENT CODE: A-1-1-P10-P13-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION AMENDED Effective date: 20250721 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20250721 |
|
| D11 | Substantive examination requested |
Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D11-D155 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: ALL REQUIREMENTS FOR EXAMINATION DETERMINED COMPLIANT Effective date: 20250725 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 5TH ANNIV.) - STANDARD Year of fee payment: 5 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20260409 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20260409 |